Sol-Gel TechnologiesSLGL
About: Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline consists of silica-based microencapsulation technology platform, and several generic product candidates across multiple indications.
Employees: 36
Fund manager confidence
Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)
150% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 2
33% more capital invested
Capital invested by funds: $3.67M [Q3] → $4.86M (+$1.2M) [Q4]
0.59% less ownership
Funds ownership: 19.35% [Q3] → 18.77% (-0.59%) [Q4]
15% less funds holding
Funds holding: 20 [Q3] → 17 (-3) [Q4]
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Research analyst outlook
We haven’t received any recent analyst ratings for SLGL.
Financial journalist opinion









